{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:29:19Z","timestamp":1790029759303,"version":"4.0.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003655","name":"National Institute of Food and Drug Safety Evaluation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.reth.2025.02.007","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T13:54:04Z","timestamp":1744638844000},"page":"404-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Regulatory insights on gene therapies, adeno-associated virus-based gene therapies, cell\/tissue-based products, and medical care\/practice in cell and gene therapies: Report from the 7th Asia partnership conference - April 25, 2024"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0608-4195","authenticated-orcid":false,"given":"Yoshie","family":"Tsurumaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0557-1901","authenticated-orcid":false,"given":"Shigeaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3027-5190","authenticated-orcid":false,"given":"Hirokuni","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Miyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruriko","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2793-0330","authenticated-orcid":false,"given":"Srinivasan N.","family":"Kellathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2025.02.007_bib1","series-title":"Technical guideline for clinical trials of human stem cell and derived cell therapy products (provisional) \u4eba\u6e90\u6027\u5e72\u7ec6\u80de\u53ca\u5176\u884d\u751f\u7ec6\u80de\u6cbb\u7597\u4ea7\u54c1\u4e34\u5e8a\u8bd5\u9a8c\u6280\u672f\u6307\u5bfc\u539f\u5219(\u8bd5\u884c)","year":"2023"},{"key":"10.1016\/j.reth.2025.02.007_bib2","series-title":"Technical guideline for clinical communication and exchanges on cell and gene therapy products (draft for comments) \u7ec6\u80de\u548c\u57fa\u56e0\u6cbb\u7597\u4ea7\u54c1\u4e34\u5e8a\u76f8\u5173\u6c9f\u901a\u4ea4\u6d41\u6280\u672f\u6307\u5bfc\u539f\u5219(\u5f81\u6c42\u610f\u89c1\u7a3f)","year":"2023"},{"key":"10.1016\/j.reth.2025.02.007_bib3","series-title":"Administrative Measures for Clinical Research of Stem Cells (Provisional) \u5e72\u7ec6\u80de\u4e34\u5e8a\u7814\u7a76\u7ba1\u7406\u529e\u6cd5(\u8bd5\u884c)","year":"2015"},{"key":"10.1016\/j.reth.2025.02.007_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/genes8020060","article-title":"Altered intracellular milieu of ADAR2-deficient motor neurons in amyotrophic lateral sclerosis","volume":"8","author":"Yamashita","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.reth.2025.02.007_bib5","article-title":"Self-complementary adeno-associated virus serotype 6 mediated knockdown of ADAMTS4 induces long-term and effective enhancement of aggrecan in degenerative human nucleus pulposus cells: a new therapeutic approach for intervertebral disc disorders","volume":"12","author":"Mern","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.reth.2025.02.007_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.reth.2025.02.007_bib7","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0883073807305788","article-title":"Consensus statement for standard of care in spinal muscular atrophy","volume":"22","author":"Wang","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.reth.2025.02.007_bib8","doi-asserted-by":"crossref","first-page":"10462","DOI":"10.1128\/JVI.00935-12","article-title":"Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network","volume":"86","author":"Xiao","year":"2012","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.reth.2025.02.007_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/ICO.0000000000001820","article-title":"Global consensus on the definition, classification, diagnosis and staging of limbal stem cell deficiency","volume":"38","author":"Deng","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.reth.2025.02.007_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.reth.2024.06.005","article-title":"Regulatory systems and requirements for clinical trials of AAV-based gene therapies \u2013 perspectives from six Asian countries or regions: report from the 6th Asia partnership conference of regenerative medicine \u2013 April 20, 2023","volume":"26","author":"Mizoguchi","year":"2024","journal-title":"Regen Ther"},{"key":"10.1016\/j.reth.2025.02.007_bib11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.reth.2024.09.015","article-title":"Regulatory insights on advanced CAR-T cell products, AAV-based gene therapies, and medical care\/practice in cell and gene therapies: report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023","volume":"26","author":"Karasawa","year":"2024","journal-title":"Regen Ther"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320425000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320425000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:31:47Z","timestamp":1763699507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320425000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":11,"alternative-id":["S2352320425000331"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2025.02.007","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory insights on gene therapies, adeno-associated virus-based gene therapies, cell\/tissue-based products, and medical care\/practice in cell and gene therapies: Report from the 7th Asia partnership conference - April 25, 2024","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2025.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier BV on behalf of The Japanese Society for Regenerative Medicine.","name":"copyright","label":"Copyright"}]}}